Uptake and distribution of doxorubicin in hormone-manipulated human breast cancer cells in vitro
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.springerlink.com/index/pdf/10.1023/A:1006026015448
Reference34 articles.
1. Launchbury AP, Habboubi N: Epirubicin and doxorubicin: a comparison of their characteristics, therapeutic activity and toxicity. Cancer Treat Rev 19: 197–228, 1993
2. The French Epirubicin Study Group: A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil, and either doxorubicin or epirubicin. J Clin Oncol 6: 679–688, 1988
3. Italian Multicenter Breast Study with Epirubicin: Phase III randomized study of fluorouracil, cpirubicin, and cyclophosphamide vs fluorouracil, doxorubicin, and cyclophos phamide in advanced breast cancer: An Italian multicenter trial. J Clin Oncol 6: 976–982, 1988
4. Levine M, Bramwell V, Pritchard K, Shepherd L: CEF versus CMF in premenopausal women — Recent update. Sixth International Conference on Adjuvant Therapy of Primary Breast Cancer, St Gallen, Switzerland, February 25–28, 1998, abstract S35
5. Liu LF, Rowe TC, Yang L, Tewey KM, Chen GL: Cleavage of DNA by mammalian DNA topoisomerase II. J Biol Chem 258: 15365–15370, 1983
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Exploring the Effect of Drug Loading on the Biological Fate of Polymer-Coated Solid Nanoparticles;Chemistry of Materials;2023-05-18
2. EMT-Activating Transcription Factor Slug is Involved in the Phenotypic Change as Well as Drug Sensitivity in Adriamycin- Resistant MCF-7 Cells;Drug Targets and Therapeutics;2023-03-31
3. Trapped! A Critical Evaluation of Methods for Measuring Total Cellular Uptake versus Cytosolic Localization;Bioconjugate Chemistry;2019-03-18
4. X-ray triggered release of doxorubicin from nanoparticle drug carriers for cancer therapy;Chemical Communications;2013
5. In Vitro Cytotoxicity of Stealth Liposomes Co-encapsulating Doxorubicin and Verapamil on Doxorubicin-Resistant Tumor Cells;Biological and Pharmaceutical Bulletin;2005
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3